Ziprasidone

Chemical formula: C₂₁H₂₁ClN₄OS  Molecular mass: 412.936 g/mol  PubChem compound: 60854

Active ingredient description

Ziprasidone has been shown to be an antagonist at both serotonin type 2A (5HT2A) and dopamine type 2 (D2) receptors. It is proposed that the therapeutic activity is mediated, in part, through this combination of antagonist activities. Ziprasidone is also a potent antagonist at 5HT2C and 5HT1D receptors, a potent agonist at the 5HT1A receptor and inhibits neuronal reuptake of norepinephrine and serotonin.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N05AE04 Ziprasidone N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
GEODON Powder for solution for injection Web Search MPI, EU: SmPC
ZIPRASIDONE MESYLATE Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
GEODON Capsule, hard Health Products Regulatory Authority (IE) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 146939-27-7
DrugBank Drug: DB00246
KEGG Drug: D08687
PubChem Compound: 60854
RxNorm Ingredient: 115698
SNOMED-CT Concept: 409356003
Ziprasidone (substance)
UNII Identifier: 6UKA5VEJ6X
ZIPRASIDONE

Medicines

Ziprasidone is an active ingredient of these brands:

United States (US)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

Australia (AU)

Austria (AT)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Brazil (BR)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

Canada (CA)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Croatia (HR)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Cyprus (CY)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

Estonia (EE)

Finland (FI)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Germany (DE)

Hong Kong (HK)

  • ZELDOX as Ziprasidone hydrochloride monohydrate
  • ZYPSILA as ZIPRASIDONE HYDROGEN SULFATE DIHYDRATE

Ireland (IE)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

Israel (IL)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

Lithuania (LT)

  • ZELDOX as Ziprasidone hydrochloride monohydrate
  • ZYPSILAN as ZIPRASIDONE HYDROGEN SULFATE DIHYDRATE

Mexico (MX)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE

New Zealand (NZ)

  • ZUSDONE as ZIPRASIDONE HYDROCHLORIDE

Poland (PL)

  • ZYPSILA as ZIPRASIDONE HYDROGEN SULFATE DIHYDRATE

Romania (RO)

  • ZYPSILA as ZIPRASIDONE HYDROGEN SULFATE DIHYDRATE

South Africa (ZA)

  • GEODON as ZIPRASIDONE HYDROCHLORIDE
  • ZIPSID as ZIPRASIDONE HYDROCHLORIDE

Spain (ES)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Tunisia (TN)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Turkey (TR)

  • ZELDOX as Ziprasidone hydrochloride monohydrate

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.